Profile data is unavailable for this security.
About the company
KISSEI PHARMACEUTICAL CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company is engaged in the collection and analysis of medicine development information, and the manufacture and sale of medicines. It is also engaged in the purchase and sale of related materials, system development and information process work, construction contract work such as new construction, expansion and renovation of factories, laboratories and offices, the management of facility and equipment work, information collection and development support work, noodle manufacture and sale, and insurance agency business.
- Revenue in JPY (TTM)81.07bn
- Net income in JPY10.73bn
- Incorporated1946
- Employees1.78k
- LocationKissei Pharmaceutical Co Ltd19-48, YoshinoMATSUMOTO-SHI 399-8710JapanJPN
- Phone+81 263259081
- Fax+81 263257899
- Websitehttps://www.kissei.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JCR Pharmaceuticals Co Ltd | 35.26bn | -437.00m | 93.89bn | 934.00 | -- | 1.60 | 30.04 | 2.66 | -3.49 | -3.49 | 281.91 | 451.84 | 0.338 | 0.4791 | 2.15 | 37,747,320.00 | -0.3864 | 8.66 | -0.5681 | 13.46 | 71.44 | 74.51 | -1.14 | 18.24 | 0.9827 | -0.3874 | 0.3325 | 30.60 | 24.83 | 13.11 | 46.00 | 8.19 | 18.54 | 21.67 |
| Kyorin Pharmaceutical Co Ltd | 119.73bn | 4.82bn | 96.85bn | 2.04k | 17.88 | 0.6623 | 10.48 | 0.8089 | 83.83 | 83.83 | 2,084.19 | 2,263.35 | 0.6745 | 1.21 | 3.18 | 58,635,650.00 | 2.71 | 3.05 | 3.36 | 3.79 | 42.87 | 47.11 | 4.02 | 4.76 | 1.74 | -- | 0.1593 | 67.74 | 5.53 | 1.02 | 12.68 | -4.98 | 7.41 | -7.06 |
| Nxera Pharma Co Ltd | 29.28bn | -3.71bn | 101.77bn | 350.00 | -- | 1.50 | 403.85 | 3.48 | -41.70 | -41.70 | 332.11 | 753.72 | 0.194 | 2.57 | 6.61 | 83,642,860.00 | -2.46 | -0.6588 | -2.76 | -0.7036 | 75.27 | 89.83 | -12.68 | -4.46 | 3.90 | -6.02 | 0.5060 | -- | -18.00 | -- | -1,982.98 | -- | -- | -- |
| Zeria Pharmaceutical Co Ltd | 81.47bn | 8.40bn | 119.20bn | 1.78k | 11.78 | 1.12 | 7.31 | 1.46 | 190.47 | 190.47 | 1,848.22 | 2,002.47 | 0.5316 | 1.50 | 3.60 | 45,846,530.00 | 5.49 | 3.89 | 8.46 | 6.28 | 72.99 | 71.93 | 10.33 | 7.57 | 0.9178 | -- | 0.3244 | 35.09 | 10.74 | 4.14 | 24.78 | 17.49 | 20.77 | 5.29 |
| Mochida Pharmaceutical Co Ltd | 104.51bn | 4.53bn | 124.21bn | 1.52k | 25.95 | 0.9103 | 16.72 | 1.19 | 127.75 | 127.75 | 2,945.16 | 3,641.81 | 0.6639 | 1.80 | 3.42 | 68,662,940.00 | 2.88 | 4.37 | 3.41 | 5.31 | 49.61 | 52.47 | 4.34 | 6.71 | 3.50 | -- | 0.00 | 45.16 | -0.3641 | -1.26 | -31.61 | -11.63 | 10.91 | -1.21 |
| Torii Pharmaceutical Co Ltd | 58.84bn | 5.28bn | 137.09bn | 583.00 | 25.36 | 1.11 | 24.06 | 2.33 | 187.71 | 187.71 | 2,093.33 | 4,271.84 | 0.4411 | 2.74 | 2.30 | 100,924,500.00 | 3.96 | 6.52 | 4.39 | 7.35 | 44.46 | 49.55 | 8.97 | 17.98 | 5.19 | -- | 0.00 | 24.17 | 11.74 | -2.67 | 4.44 | 28.76 | -20.38 | 20.11 |
| Towa Pharmaceutical Co Ltd | 243.94bn | 15.78bn | 145.28bn | 4.59k | 8.80 | 0.8725 | 4.20 | 0.5955 | 320.50 | 320.50 | 4,956.02 | 3,232.16 | 0.5838 | 1.52 | 3.93 | 53,169,570.00 | 3.78 | 4.21 | 4.56 | 5.63 | 36.10 | 39.23 | 6.47 | 7.23 | 1.63 | -- | 0.581 | 21.01 | 9.13 | 16.74 | 634.80 | 3.72 | 28.20 | 10.86 |
| Kissei Pharmaceutical Co Ltd | 81.07bn | 10.73bn | 180.23bn | 1.78k | 15.12 | 0.7356 | 11.80 | 2.22 | 241.71 | 241.71 | 1,825.83 | 4,969.03 | 0.3294 | 1.60 | 2.98 | 45,568,860.00 | 4.38 | 3.61 | 4.75 | 3.90 | 49.88 | 49.47 | 13.31 | 12.69 | 4.15 | -- | 0.0057 | 34.87 | 11.98 | 0.8919 | 6.00 | 15.28 | 6.58 | 10.40 |
| KAKEN PHARMACEUTICAL CO., LTD. | 87.25bn | 18.24bn | 204.94bn | 1.14k | 9.26 | 1.09 | 9.81 | 2.35 | 481.71 | 481.71 | 2,303.80 | 4,076.80 | 0.4864 | 1.98 | 3.88 | 76,867,840.00 | 10.17 | 6.83 | 11.66 | 7.87 | 60.66 | 54.78 | 20.91 | 14.48 | 4.47 | -- | 0.0243 | 51.25 | -1.29 | -5.21 | 47.52 | -14.70 | 0.3639 | 0.00 |
| Sumitomo Pharma Co Ltd | 342.67bn | -279.46bn | 242.32bn | 4.98k | -- | 2.12 | -- | 0.7072 | -703.41 | -703.41 | 862.50 | 287.37 | 0.3517 | 1.30 | 4.28 | 68,808,230.00 | -28.68 | -5.07 | -51.21 | -7.73 | 59.56 | 69.99 | -81.54 | -12.28 | 0.424 | -12.10 | 0.7732 | -- | -43.38 | -7.29 | -322.71 | -- | 4.02 | -- |
| Sawai Group Holdings Co Ltd | 177.34bn | 16.55bn | 259.26bn | 3.48k | 15.58 | 1.21 | 9.13 | 1.46 | 126.61 | 184.41 | 1,357.79 | 1,623.19 | 0.4658 | 1.12 | 2.83 | 50,929,920.00 | 3.17 | 0.7104 | 4.24 | 0.9705 | 30.73 | 35.08 | 6.80 | 1.47 | 1.39 | 38.13 | 0.3169 | 88.13 | 8.04 | -0.8249 | 46.82 | -2.33 | 18.15 | 0.00 |
Data as of Nov 25 2024. Currency figures normalised to Kissei Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY
16.10%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Brandes Investment Partners LPas of 15 May 2024 | 2.54m | 5.15% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 1.30m | 2.63% |
| Nomura Asset Management Co., Ltd.as of 07 Nov 2024 | 1.01m | 2.05% |
| Wellington Management Co. LLPas of 31 Oct 2024 | 576.35k | 1.17% |
| Nikko Asset Management Co., Ltd.as of 08 Nov 2024 | 484.60k | 0.98% |
| JPMorgan Asset Management (Japan) Ltd.as of 30 Sep 2024 | 478.30k | 0.97% |
| Daiwa Asset Management Co. Ltd.as of 31 Oct 2024 | 458.30k | 0.93% |
| BlackRock Fund Advisorsas of 07 Nov 2024 | 399.20k | 0.81% |
| Dimensional Fund Advisors LPas of 31 Oct 2024 | 390.91k | 0.79% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 303.50k | 0.62% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
